CompletedEarly Phase 1NCT05995626
Hyaluronidase Via LADD Scleroderma-induced Microstomia
Studying Neonatal scleroderma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Nebraska
- Principal Investigator
- Sarah L Lonowski, MD, M.DUniversity of Nebraska
- Intervention
- Hyaluronidase(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 19 years · All sexes
- Timeline
- 2024 – 2024
Study locations (2)
- University of Nebraska Medical Center, Lauritzen Outpatient Center, Omaha, Nebraska, United States
- Nebraska Medicine, Dermatology Westroads, Omaha, Nebraska, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05995626 on ClinicalTrials.gov